SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-004229
Filing Date
2015-05-14
Accepted
2015-05-14 06:08:18
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fprx-10q_20150331.htm 10-Q 1084059
2 EX-31.1 fprx-ex311_201503316.htm EX-31.1 8341
3 EX-31.2 fprx-ex312_201503318.htm EX-31.2 8359
4 EX-32.1 fprx-ex321_201503317.htm EX-32.1 5217
5 EX-32.2 fprx-ex322_201503319.htm EX-32.2 5133
6 GRAPHIC g201505132305414572633.jpg GRAPHIC 32954
  Complete submission text file 0001564590-15-004229.txt   4929944

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT fprx-20150331.xml EX-101.INS 808423
8 XBRL TAXONOMY EXTENSION SCHEMA fprx-20150331.xsd EX-101.SCH 24307
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fprx-20150331_cal.xml EX-101.CAL 33625
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fprx-20150331_def.xml EX-101.DEF 49167
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE fprx-20150331_lab.xml EX-101.LAB 193107
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fprx-20150331_pre.xml EX-101.PRE 132640
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36070 | Film No.: 15860191
SIC: 2834 Pharmaceutical Preparations